Agenda I standing is reserved for substances which has a substantial potential for abuse, no at the moment accepted use for treatment in the United States and an absence of recognized protection criteria to be used less than healthcare supervision.[thirty]33 in comparison to methylphenidate for the same purpose. This is based on its binding toughne